These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19493055)

  • 41. Effect of anti-T cell autoantibodies from systemic lupus erythematosus sera upon T lymphocyte functions.
    Goldschmidt LP; Kresina TF; Kammer GM
    Arthritis Rheum; 1986 May; 29(5):646-54. PubMed ID: 3487322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus.
    Bates RL; Payne SJ; Drury SL; Nelson PN; Isenberg DA; Murphy JJ; Frampton G
    Lupus; 2003; 12(8):617-22. PubMed ID: 12945721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proliferation-associated Ki-67 protein is a target for autoantibodies in the human autoimmune disease systemic lupus erythematosus.
    Gerlach C; Kubbutat M; Schwab U; Key G; Flad HD; Gerdes J
    Lab Invest; 1998 Jan; 78(1):129-30. PubMed ID: 9461130
    [No Abstract]   [Full Text] [Related]  

  • 44. Systemic Lupus Erythematosus: Correlation Between Immunodysregulation and Clinical Manifestations.
    Carneiro OI; Brito IH
    Curr Rheumatol Rev; 2016; 12(2):154-61. PubMed ID: 26496783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunopathology of systemic lupus erythematosus].
    Bach JF
    Rev Med Interne; 2000 Dec; 21 Suppl 4():456s. PubMed ID: 11347482
    [No Abstract]   [Full Text] [Related]  

  • 46. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases.
    Maddison P; Mogavero H; Provost TT; Reichlin M
    J Rheumatol; 1979; 6(2):189-95. PubMed ID: 88520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B cells and atherosclerosis in systemic lupus erythematosus.
    Koulouri V; Koutsilieris M; Mavragani CP
    Expert Rev Clin Immunol; 2019 Apr; 15(4):417-429. PubMed ID: 30652925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The IL-12-STAT4 axis in the pathogenesis of human systemic lupus erythematosus.
    Ueno H
    Eur J Immunol; 2020 Jan; 50(1):10-16. PubMed ID: 31762023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematosus and their clinical relevance. I. DNA-binding autoantibodies].
    Wollina U
    Allerg Immunol (Leipz); 1983; 29(3):127-34. PubMed ID: 6227213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and resolution of secondary autoimmunity after autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: competition of plasma cells for survival niches?
    Alexander T; Schneider S; Hoyer B; Cheng Q; Thiel A; Ziemer S; Burmester GR; Arnold R; Radbruch A; Hiepe F
    Ann Rheum Dis; 2013 Jun; 72(6):1102-4. PubMed ID: 23361083
    [No Abstract]   [Full Text] [Related]  

  • 51. Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus.
    Arribas J; Luz Rodríguez M; Alvarez-Do Forno R; Castaño JG
    J Exp Med; 1991 Feb; 173(2):423-7. PubMed ID: 1703207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-CRP autoantibody levels correlate with disease activity in systemic lupus erythematosus.
    Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
    Semin Arthritis Rheum; 2005 Aug; 35(1):65; author reply 66. PubMed ID: 16084226
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.
    Winfield JB; Fernsten P; Czyzyk J; Wang E; Marchalonis J
    Springer Semin Immunopathol; 1994; 16(2-3):201-10. PubMed ID: 7716705
    [No Abstract]   [Full Text] [Related]  

  • 54. Gender disparity in systemic lupus erythematosus, thoughts after the 8th International Congress on Systemic Lupus Erythematosus, Shanghai, China, 2007.
    Lahita RG
    J Clin Rheumatol; 2008 Jun; 14(3):185-7. PubMed ID: 18525443
    [No Abstract]   [Full Text] [Related]  

  • 55. B cells biology in systemic lupus erythematosus-from bench to bedside.
    Zhao L; Ye Y; Zhang X
    Sci China Life Sci; 2015 Nov; 58(11):1111-25. PubMed ID: 26563177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoantibodies and SLE.
    Ziminski CM
    Md Med J; 1991 Oct; 40(10):901-8. PubMed ID: 1943519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Thrombosis, antibodies, and systemic lupus erythematosus].
    Cardiel MH; Gamba G
    Rev Invest Clin; 2000; 52(1):86-8. PubMed ID: 10818815
    [No Abstract]   [Full Text] [Related]  

  • 58. Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity.
    Gruber BL; Kaufman LD; Marchese MJ; Roth W; Kaplan AP
    Arthritis Rheum; 1988 Aug; 31(8):1000-6. PubMed ID: 3408506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction in the percentage of circulating variable delta 2 T cells in systemic lupus erythematosus.
    Koga T; Endo Y; Umeda M; Sato T; Mizunoo Y; Furukawa K; Shimizu T; Sumiyoshi R; Kawashiri SY; Iwamoto N; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kawakami A
    Clin Immunol; 2020 Nov; 220():108577. PubMed ID: 32858205
    [No Abstract]   [Full Text] [Related]  

  • 60. Vesiculobullous systemic lupus erythematosus: a case with circulating IgG and IgA autoantibodies to type VII collagen.
    Nitta Y; Kawamura C; Hashimoto T
    J Am Acad Dermatol; 2002 Nov; 47(5 Suppl):S283-6. PubMed ID: 12399753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.